Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis
Status:
Recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
This study aims to confirm whether the preventive use of ursodeoxycholic acid on the 5th day
after birth in preterm infants who started parenteral nutrition therapy can reduce the
occurrence of enteral nutrition-related cholestasis in preterm infants. This study examined
the safety and efficacy of ursodeoxycholic acid (UDCA) in preventing Cholestasis Associated
with Total Parenteral Nutrition in preterm infants.